- Do you own shares of ViroPharma Incorporated (NASDAQ GS: VPHM )?
- Did you purchase any of your shares prior to November 11, 2013?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
The Consumer Union is alleging that Mylan may have paid Teva to withhold its EpiPen competitor from the market.
When it comes to investing in health care, hedge fund pro John Paulson knows his stuff.